ApicHope(SZ:300723) Xin Lang Cai Jing·2025-10-13 02:38Group 1 - The core viewpoint of the news is that Yipinhong Pharmaceutical Group Co., Ltd. has seen a significant stock price increase of 5.35%, reaching 61.40 CNY per share, with a total market capitalization of 27.734 billion CNY [1] - Yipinhong's main business involves the research, production, and sales of its own pharmaceuticals, as well as the sales of agent pharmaceuticals, with revenue composition being 61.12% from children's medicine, 22.71% from chronic disease medicine, and 16.17% from other products [1] Group 2 - From the perspective of fund holdings, Yipinhong is a significant investment for Huabao Fund, with its Huabao Medical Biotechnology Mixed A Fund holding 373,000 shares, accounting for 3.59% of the fund's net value, making it the ninth largest holding [2] - The Huabao Medical Biotechnology Mixed A Fund has achieved a year-to-date return of 57.32%, ranking 622 out of 8234 in its category, and a one-year return of 41.08%, ranking 1680 out of 8083 [2] Group 3 - The fund manager of Huabao Medical Biotechnology Mixed A Fund is Zhang Jintao, who has been in the position for nearly 10 years, with the fund's total asset size at 1.202 billion CNY [3] - During Zhang's tenure, the best fund return was 62.24%, while the worst return was -14.23% [3]